FMP
PROCEPT BioRobotics Corporation
PRCT
NASDAQ
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
81.17 USD
0.39 (0.48%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Dr. Reza Zadno Ph.D.
sector
Healthcare
industry
Medical - Devices
exchange
NASDAQ
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
CIK
0001588978
ISIN
US74276L1052
CUSIP
74276L105
Address
900 Island Drive
Phone
650 232 7200
Country
US
Employee
626
IPO Date
Sep 15, 2021
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
PRCT Financial Summary
CIK
0001588978
Exchange
NASDAQ
Industry
Medical - Devices
Sector
Healthcare
CUSIP
74276L105
ISIN
US74276L1052
Country
US
Price
81.17
Beta
1
Volume Avg.
810.71k
Market Cap
4.42B
Shares
-
52-Week
39.48-103.81
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-41.63
P/B
-
Website
https://www.procept-biorobotics.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest PRCT News
It looks like there's no news available.
